Cargando…

Promoter methylation of Wrap53α, an antisense transcript of p53, is associated with the poor prognosis of patients with non-small cell lung cancer

Lung cancer, of which non-small cell lung cancer (NSCLC) accounts for ~85% of cases, remains a leading cause of cancer-associated mortality and morbidity worldwide. Tumor suppressor p53 is a master regulator of diverse cellular processes and is a therapeutic target in cancer. However, many aspects o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dong Sun, Lee, Won Kee, Park, Jae Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176374/ https://www.ncbi.nlm.nih.gov/pubmed/30344734 http://dx.doi.org/10.3892/ol.2018.9404

Ejemplares similares

CTCF regulates the human p53 gene through direct interaction with its natural antisense transcript, Wrap53
por: Saldaña-Meyer, Ricardo, et al.
Publicado: (2014)

Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors
por: Zhu, Yan, et al.
Publicado: (2023)

TGFBI Promoter Methylation is Associated with Poor Prognosis in Lung Adenocarcinoma Patients
por: Seok, Yangki, et al.
Publicado: (2019)

Nuclear WRAP53 promotes neuronal survival and functional recovery after stroke
por: Sánchez-Morán, Irene, et al.
Publicado: (2020)

The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset
por: Gadelha, Renan Brito, et al.
Publicado: (2022)

WRAP53 promotes cancer cell survival and is a potential target for cancer therapy
por: Mahmoudi, S, et al.
Publicado: (2011)

Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer
por: Pouladi, Nasser, et al.
Publicado: (2019)

On the road with WRAP53β: guardian of Cajal bodies and genome integrity
por: Henriksson, Sofia, et al.
Publicado: (2015)

Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis
por: Iwahashi, Naoyuki, et al.
Publicado: (2022)

Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma
por: Chen, Jiewei, et al.
Publicado: (2017)

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population
por: Mędrek, Krzysztof, et al.
Publicado: (2012)

Overexpression of WRAP53 Is Associated with Development and Progression of Esophageal Squamous Cell Carcinoma
por: Rao, Xuguang, et al.
Publicado: (2014)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
por: Silwal-Pandit, Laxmi, et al.
Publicado: (2015)

High α B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer
por: Tan, Lin, et al.
Publicado: (2019)

Phosphorylation of the Cajal body protein WRAP53β by ATM promotes its involvement in the DNA damage response
por: Coucoravas, Christos, et al.
Publicado: (2016)

Expression of WDR79 is associated with TP53 mutation and poor prognosis in surgically resected non-small cell lung cancer
por: Peng, Jinwu, et al.
Publicado: (2019)

Downregulation of the cancer susceptibility protein WRAP53β in epithelial ovarian cancer leads to defective DNA repair and poor clinical outcome
por: Hedström, E, et al.
Publicado: (2015)

Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression.
por: Barton, C. M., et al.
Publicado: (1995)

Oncogenic Activity of Wrap53 in Human Colorectal Cancer In Vitro and in Nude Mouse Xenografts
por: Zhu, Yu, et al.
Publicado: (2018)

Antibodies against p53 are associated with poor prognosis of colorectal cancer.
por: Houbiers, J. G., et al.
Publicado: (1995)

p53 protein expression in nephroblastomas: a predictor of poor prognosis.
por: Govender, D., et al.
Publicado: (1998)

p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010)

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer
por: Iwaya, Keiichi, et al.
Publicado: (1991)

Diaphyseal and Metaphyseal Modeling Defects—Clinical Findings and Identification of WRAP53 Deficiency in Craniometadiaphyseal Dysplasia
por: Hao, Yun, et al.
Publicado: (2021)

Wild-Type TP53 Predicts Poor Prognosis in Patients with Gastric Cancer
por: Deng, Wenhong, et al.
Publicado: (2021)

Tp53 disruptions: is there a marker of poor prognosis in chronic lymphoproliferative disorders?
por: Cencini, Emanuele, et al.
Publicado: (2021)

Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
por: Peng, Jianbo, et al.
Publicado: (2023)

Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity
por: van der Weyden, L, et al.
Publicado: (2013)

Polymorphisms in Apoptosis-Related Genes and TP53 Mutations in Non-Small Cell Lung Cancer
por: Bae, Eun Young, et al.
Publicado: (2011)

Genomic landscape and prognosis of patients with TP53-mutated non-small cell lung cancer
por: Fan, Zhisong, et al.
Publicado: (2022)

WRAP53 Is Essential for Cajal Body Formation and for Targeting the Survival of Motor Neuron Complex to Cajal Bodies
por: Mahmoudi, Salah, et al.
Publicado: (2010)

TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients
por: Zhang, Jian, et al.
Publicado: (2022)

DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism
por: Chen, Ling, et al.
Publicado: (2019)

CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer
por: Xie, Jie, et al.
Publicado: (2018)

Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis
por: Zheng, Chang, et al.
Publicado: (2020)

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma
por: Seng, T J, et al.
Publicado: (2008)

Downregulation of ZNF365 by methylation predicts poor prognosis in patients with colorectal cancer by decreasing phospho-p53 (Ser15) expression
por: Wang, Chan, et al.
Publicado: (2020)

PRMT5 promotes DNA repair through methylation of 53BP1 and is regulated by Src-mediated phosphorylation
por: Hwang, Jee Won, et al.
Publicado: (2020)

Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations
por: Canale, Matteo, et al.
Publicado: (2022)

Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non–Small Cell Lung Cancer
por: Zhu, Lihuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6pth6s9uesahbn2nls4ntkdml7